KMT2C and lung carcinoma: Mutations also occur in chromatin-modifying genes, such as ARID1A, ARID2, SETD2, SMARCA4 and MLL3 (KMT2C), leading to epigenomic abnormalities that overlap with genomic alterations, further complicating lung cancer biology.